These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28601328)

  • 21. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
    Koulaouzidis A; Douglas S; Rogers MA; Arnott ID; Plevris JN
    Scand J Gastroenterol; 2011 May; 46(5):561-6. PubMed ID: 21269246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.
    Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI
    Gastrointest Endosc; 2017 Dec; 86(6):1070-1078. PubMed ID: 28947363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn's Disease.
    Monteiro S; Barbosa M; Cúrdia Gonçalves T; Boal Carvalho P; Moreira MJ; Rosa B; Cotter J
    Inflamm Bowel Dis; 2018 Aug; 24(9):2033-2038. PubMed ID: 29722829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Keenan JI; Leach S; Burgess L; Aitchison A; Gorelik A; Liew D; Day AS; Gearry RB
    Inflamm Bowel Dis; 2016 May; 22(5):1086-94. PubMed ID: 26818420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lewis score correlates more closely with fecal calprotectin than Capsule Endoscopy Crohn's Disease Activity Index.
    Koulaouzidis A; Douglas S; Plevris JN
    Dig Dis Sci; 2012 Apr; 57(4):987-93. PubMed ID: 22057284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.
    Goutorbe F; Goutte M; Minet-Quinard R; Boucher AL; Pereira B; Bommelaer G; Buisson A
    J Crohns Colitis; 2015 Dec; 9(12):1113-9. PubMed ID: 26351383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal calprotectin is a strong predictive marker of relapse in Chinese patients with Crohn's disease: a two-year prospective study.
    Ye L; Chen BQ; Wang SD; Shi H; Yang Z; Wang FY
    Scand J Gastroenterol; 2017 Oct; 52(10):1113-1119. PubMed ID: 28675068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease.
    Naismith GD; Smith LA; Barry SJ; Munro JI; Laird S; Rankin K; Morris AJ; Winter JW; Gaya DR
    J Crohns Colitis; 2014 Sep; 8(9):1022-9. PubMed ID: 24566170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.
    Faubion WA; Fletcher JG; O'Byrne S; Feagan BG; de Villiers WJ; Salzberg B; Plevy S; Proctor DD; Valentine JF; Higgins PD; Harris JM; Diehl L; Wright L; Tew GW; Luca D; Basu K; Keir ME
    Am J Gastroenterol; 2013 Dec; 108(12):1891-900. PubMed ID: 24126633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal calprotectin in the prediction of postoperative recurrence of Crohn's disease in children and adolescents.
    Hukkinen M; Pakarinen MP; Merras-Salmio L; Koivusalo A; Rintala R; Kolho KL
    J Pediatr Surg; 2016 Sep; 51(9):1467-72. PubMed ID: 26891835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
    Bodelier AG; Jonkers D; van den Heuvel T; de Boer E; Hameeteman W; Masclee AA; Pierik MJ
    Dig Dis Sci; 2017 Feb; 62(2):465-472. PubMed ID: 27933473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profile of Consecutive Fecal Calprotectin Levels in the Perioperative Period and Its Predictive Capacity for Early Endoscopic Recurrence in Crohn's Disease.
    Liu R; Guo Z; Cao L; Wang Z; Gong J; Li Y; Zhu W
    Dis Colon Rectum; 2019 Mar; 62(3):318-326. PubMed ID: 30451756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inokuchi T; Kato J; Hiraoka S; Takashima S; Nakarai A; Takei D; Sugihara Y; Takahara M; Kawano S; Harada K; Okada H
    Inflamm Bowel Dis; 2016 May; 22(5):1078-85. PubMed ID: 26891256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
    Egea Valenzuela J; Pereñíguez López A; Pérez Fernández V; Alberca de Las Parras F; Carballo Álvarez F
    Rev Esp Enferm Dig; 2016 Jul; 108(7):394-400. PubMed ID: 27312194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.
    Daniluk U; Daniluk J; Krasnodebska M; Lotowska JM; Sobaniec-Lotowska ME; Lebensztejn DM
    Adv Med Sci; 2019 Mar; 64(1):9-14. PubMed ID: 30237086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission.
    Raftery T; Merrick M; Healy M; Mahmud N; O'Morain C; Smith S; McNamara D; O'Sullivan M
    Dig Dis Sci; 2015 Aug; 60(8):2427-35. PubMed ID: 25757449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon.
    Jensen MD; Kjeldsen J; Nathan T
    Scand J Gastroenterol; 2011 Jun; 46(6):694-700. PubMed ID: 21456899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.